News
Taiwan FDA approves Chugai Pharma’s PiaSky for subcutaneous treatment of patients with paroxysmal nocturnal hemoglobinuria: Tokyo Tuesday, May 20, 2025, 10:00 Hrs [IST] Chugai P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback